The Interrelationship between Diabetes Mellitus and COVID-19
Thekra Abdulaali Abed, Zainab Adil Ghani Chabuck
Abstract
The pandemic of coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has involved more than 100 million individuals, including more than 2 million deaths. Diabetes represents one of the most prevalent chronic conditions worldwide and significantly increases the risk of hospitalization and death in patients with COVID-19. In this review, we discuss the prevalence, the pathophysiological mechanisms, and the outcomes of COVID-19 infection in people with diabetes. We propose a rationale for using drugs prescribed in patients with diabetes and some pragmatic clinical recommendations to deal with COVID-19 in this kind of patient.
Topics & Concepts
MedicineDiabetes mellitusCoronavirus disease 2019 (COVID-19)PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseCoronavirus2019-20 coronavirus outbreakIntensive care medicineInternal medicineVirologyInfectious disease (medical specialty)EndocrinologyOutbreakCOVID-19 Clinical Research StudiesDiabetes Management and ResearchDiabetes and associated disorders